Introduction
Macrophages are highly plastic phagocytic cells responsible for the maintenance of physiological homeostasis due to their ability to clear pathogens and influence the behavior of other immune cells (1) . They are activated by pathogen associated molecular patterns through specific receptors to generate an inflammatory response characterized by a cascade of cytokines and molecules that limit ongoing infection or tissue damage. Excessive macrophage activation responses, however, can lead to acute pathological diseases, best exemplified by sepsis, or chronic disorders such as arthritis, asthma, atherosclerosis or diabetes type 2 (1). LPS-stimulated macrophages accumulate triacylglycerol (TAG) molecules, which are used to meet the increased demands of energy of these highly active cells (6, 7) .
Engagement of Toll-like receptors (TLR)
TAG is formed by acylation of part of the DAG generated via the Kennedy pathway of phospholipid synthesis (8) . The enzymes that directly generate diacylglycerol (DAG), in the Kennedy pathway, display phosphatidic acid phosphatase activity are a family known as the lipins (9, 10) . We have previously shown that a member of this family of enzymes, lipin-1, is expressed in human macrophages, and regulates eicosanoid production and size and number of TAG-loaded lipid droplets (11) . However, little is known about the role of lipin-1 during macrophage activation through TLRs. Questions on the possible involvement of lipin-1 on the production of DAG during TLR stimulation, the role of lipin-1 during TLR signaling, whether lipin-1 activity modulates proinflammatory gene upregulation, and whether lipin-1 influences inflammatory 4 conditions in vivo remain unanswered. Here we have used genetic and omics approaches to determine the role of lipin-1 during TLR activation of macrophages. We report that lipin-1 contributes positively to macrophage stimulation through TLR4, and other TLRs, by impacting on MAPKs and AP-1 activation and as a consequence, on the generation of proinflammatory factors during in vitro and in vivo models of inflammation. Thus, lipin-1 connects lipid synthesis with macrophage proinflammatory activation.
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Materials and Methods

Animals
Reagents
LPS from Escherichia coli 0111:B4, 1,2-diheptadecanoyl-sn-glycerol and the antibody against β−actin were obtained from Sigma-Aldrich. Antibodies against IκBα, IκBβ, phospho-p38 MAPK (Thr180/Tyr182), p38 MAPK, phospho-p44/42 MAPK (Thr202/Tyr204), p44/42 MAPK, phospho-SAPK/JNK (Thr183/Tyr185), SAPK/JNK and phospho-c-Jun were purchased from Cell Signaling. Antibodies against the nuclear protein p84 were from Abcam. Antibodies against iNOS were from BD Biosciences and anti-COX-2 from Cayman. The rabbit antiserum against lipin-1 was previously described (11) . PE-conjugated antibodies against CD11b, APC-conjugated antibodies against F4/80, FITC-conjugated antibodies against Gr1 and 7-amino-actinomycin D were purchased from ebiosciences. Specific ON-Target plus siRNAs against murine mRNAs were obtained from Dharmacon (Thermo Scientific). Silencer® Select siRNAs specific to decrease the expression of human lipin-1 mRNA and negative controls were purchased from Ambion.
Cells
To obtain peritoneal macrophages, the peritoneal cavity was flushed twice with 5 ml of 6 ice-cold PBS. Resident cells were centrifuged for 10 min at 300 x g, and allowed to adhere to plastic for 18 h in RPMI 1640 medium containing 10% fetal bovine serum.
Non-adherent cells were washed away, and attached cells were maintained in culture until use.
To obtain bone marrow-derived macrophages (BMDMs), intact femurs and tibias were aseptically dislocated from the hind legs of the mice. The marrow was flushed with 5 ml of PBS using a 25 g sterile needle. After filtration, bone marrow cells were centrifuged for 10 min at 300 x g, cultured and differentiated according to the procedure described by Johnson et al. (13) . Briefly, the cells were cultured in growth medium supplemented with 20% supernatant of the mouse L929 cell (conditioned medium) and cultured for 7 days. The medium was changed at day 4, washing out the non-adherent cells and differentiation was continued for a total of 7 days.
Neutrophils were isolated from bone marrow using a Percoll® gradient as described (14) . T and B lymphocyte populations were isolated from spleen using nylon wool columns (15) . Briefly, splenocytes were depleted of erythrocytes by ammonium chloride-mediated lysis. Cells were then incubated in plastic plates at 37 o C and 5%CO 2 for 2 h. Non-adherent cells containing mainly B and T cells were further subjected to nylon wool (Polysciences, Inc.) purification, allowing them to adhere to the column at Human macrophages were obtained from blood monocytes and transfected using the nucleofection technique (Amaxa), as previously described (11, (16) (17) (18) ).
Measurement of DAG mass
A cell extract corresponding to 1 mg of protein was used and, before the extraction and separation of lipid classes, 1,2-diheptadecanoyl-sn-glycerol was added as an internal standard. Total lipids were extracted according to Bligh and Dyer (19) , and the resulting lipid extract was separated by thin-layer chromatography using n- 
Real time PCR
Total RNA from mouse tissues and cells was extracted using RNeasy Mini Kit (Quiagen)
and Trizol reagent (Ambion) respectively. The cDNA templates were synthesized using M-MLW Reverse Transcriptase (Ambion) following the manufacturer instructions.
Quantitative real time (RT)-PCR analysis was performed in a LightCycler® 480 (Roche)
as previously described (18) using specific primers obtained from the Primer Bank data base (23) .
Cytokine determination and serum analysis
Supernatants from activated cells or serum from LPS-treated animals were used for quantification of IL-6, IL12p40, IL2p70 and IL23p19 by specific ELISA kits (eBioscience)
following the manufacturer's instructions. Urea, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) measurements in serum were kindly performed by Laboratorios Echevarne (Barcelona, Spain). 8 
LPS treatment of animals
Mice were intraperitoneally injected with LPS at a lethal dose of 25 mg/kg or a sublethal dose of 1.5 mg/kg and monitored for 10 days. For the analysis of proinflammatory factors some animals were sacrificed by ketamine (100 mg/kg):
xylacine (10 mg/kg) administration and cervical dislocation 6 hours after LPS treatment. Blood was collected through cardiac puncture or from the facial vein. Livers and spleens were collected in RNAlater (Ambion) for further analysis by real-time PCR. 
Microarray gene expression
Flow cytometry
Cells from whole spleen or peritoneal lavage were incubated with antibodies against CD16/CD32 (eBiosciences) to block nonspecific antibody binding to Fc receptors. Cells were then stained with PE-conjugated rat anti-mouse CD11b IgG2b, APC-conjugated rat anti-mouse F4/80 IgG2a and FITC-conjugated rat anti-mouse Gr1 IgG2b
(ebiosciences). Isotype control antibodies were used to subtract background staining.
Staining with 7-amino-actinomycin D was also performed to exclude nonviable cells 9 during the analysis. Data collection was performed in a Beckman Coulter Gallios flow cytometer and data analyses were performed using the Kaluza software.
DNA Binding Assays
The DNA binding activity of nuclear c-Jun was assayed by a commercial kit (Active Motif) following the manufacturer's instructions.
Constructs and Transfections
Lipin1β-EGFP plasmid was constructed by introducing the cDNA sequence of the mouse Lpin1b (Thermo Scientific, clone 4211202) in the EGFP expression vector pEGFP-N3 (Clontech) by using EcoRI and SalI restriction enzymes. The primers used were as follows: 5´-CACACAGAATTCAATGAATTACGTGGGGCAGC-3´ and 5´-CACACAGTCGACAGCTGAGGCTGAATGCATGT-3. Confirmation of the correct insertion of the cDNA was performed by sequencing. Plasmids (EGFP or lipin1-EGFP) were transfected into BMDMs by using the Nucleofection method, and the kit specifications for murine macrophages were followed. 3 µg of plasmid was used and the program was Y-001.
Statistical analysis
Data are represented as means ± standard error of the mean (SEM). Statistical significance was determined by Student's t test. p<0.05 was considered statistically significant.
Results
Lipin-1 deficient macrophages have a decreased inflammatory gene expression after TLR4 stimulation
We began this study by analyzing the expression levels of lipin- Again, the absence of lipin-1 led to reduced responses to LPS (Fig. 2B) . A more exhaustive analysis in bone marrow-derived macrophages (BMDMs) indicated that many inflammation-related genes were affected in fld derived cells, including Il12a (p35), Il23a (p19), Tnfa, and Ifng (Fig. 2C) . These results were also corroborated by analysis of protein levels in the supernantants or cell homogenates of TLR4-activated cells ( Fig. 2D and E) . The observed responses were not due to a lower expression of TLR4 in the fld macrophages, as the latter cells expressed TLR4 at levels identical to wt cells (data not shown). Also, no differences in macrophage cell surface markers were found between wt and fld BMDMs, suggesting no differences in their level of 11 differentiation (Supplemental Fig. 2 ). Collectively, these results suggest that lipin-1 is centrally involved in the inflammatory response to TLR4 occupancy in macrophages.
Lipin-1 deficient macrophages show a distinctive gene expression pattern after TLR4
stimulation.
To obtain a broader view of lipin-1 regulated genes during LPS activation, gene expression was analyzed by RNA microarrays in BMDMs stimulated with LPS during 5 h ( Table 1 ), which indicates that lipin-1 might be relevant not only for the proinflammatory response, but also for other processes during the macrophage response to pathogens.
Lipin-1 deficient macrophages have altered responses to other TLRs
To assess whether signaling through other TLRs is also affected in fld macrophages, experiments were conducted using the TLR3 ligand poly(I:C) and the TLR1/2 ligand Pam3CSK4. Evaluation of the expression of proinflammatory genes showed that mRNA levels for Il6 and Il13a were lower in poly(I:C)-stimulated fld macrophages while Nos2
and Cox2 were not affected (Fig. 4A) . Also, fld cells stimulated with Pam3CSK4 exhibited lower mRNA levels for Il6, Il23a and Nos2 than wt cells (Fig. 4B) . We also examined the effects of non classical TLR4 activators such as the saturated fatty acid palmitic acid (24) . In line with our findings with LPS, the effects of palmitic acid were diminished in fld cells (Fig. 4C) . Thus, these results suggest that the diminished inflammatory response of fld macrophages is not restricted to a particular TLR but rather works at a more general level during cell activation.
Lipin-1 deficient macrophages exhibit altered TLR4 signaling
We next evaluated whether TLR4 signaling pathways are affected in lipin-1 deficient cells. As illustrated in Fig. 5 , fld macrophages responding to LPS showed a reduced phosphorylation of the MAPK family members p44/p42 ERKs, JNK and p38 (Fig. 5A, B) .
Of note, phosphorylation and nuclear activity of the downstream protein c-jun, which forms part of the transcription factor AP-1, was also diminished in LPS-stimulated macrophages from fld mice (Fig. 5C, D) . We also examined the degradation of the NF-κB inhibitors, IκBα and IκBβ in fld macrophages, and found no significant differences when compared to wt cells (Fig. 5E) . Hence, these data suggest that diminished activation of MAPK/AP-1, but not NF-κB, is responsible for the reduced proinflammatory behavior observed in fld macrophages. Therefore, not all TLR4-mediated signaling seems to be affected by lipin-1 depletion, but only the branch that is downstream to MAPK activation.
Because the enzymatic activity of lipin-1 produces DAG, experiments were conducted next to evaluate the involvement of lipin-1 in DAG generation during TLR4 activation.
DAG production by LPS in fld and wt macrophages was analyzed by mass spectrometry.
In wt macrophages, LPS stimulation promoted a time-dependent increase in total cellular DAG mass (Fig. 5F ). Importantly, in fld cells the opposite situation occurred, and DAG levels not only did not increase but actually decreased after LPS activation, thus suggesting that in the absence of lipin-1 the degradation of DAG and/or its conversion to other products predominates over its accumulation (Fig. 5F ).
Collectively, these data are consistent with lipin-1 being a major mediator of early DAG generation in LPS activated macrophages.
Experiments were also conducted to assess whether expressing lipin-1 in fld macrophages restores the proinflammatory responses of these cells. Fld BMDMs were transiently transfected with a plasmid encoding for lipin-1, and ERK-1/2 phosphorylation and iNOS expression was analyzed by immunoblot. The results, as shown in Fig. 6 , clearly show that lipin-1 expression restored these two responses.
Analysis of LPS-stimulated DAG production in the oreover, transfecting the cells with lipin-1 also restored the DAG response to LPS 13 t Thus, transfecting in lipin-1 also restores DAG synthesis and the DAG response to LPS
Lipin-1 deficient mice have a quicker recovery from endotoxin treatment
To define the in vivo implication of the above findings, the effect of an i.p.
administration of LPS was evaluated in animals. At high doses of LPS (25 mg/Kg) there
were not significant differences in mortality rates between wt and fld animals (Fig. 7A) .
However, at lower LPS doses (1.5 mg/Kg), which did not provoke death, fld animals had a faster weight recovery than wt animals (Fig. 7B) . While fld animals returned to their original weight after 6 days of treatment, wt animals needed longer than 10 days to recover, suggesting that fld animals resolve the injury faster. Furthermore, analyses of urea, BUN, creatinine, AST and ALT in serum from fld versus wt animals showed reduced levels in the former, thus suggesting a less pronounced organ damage (Fig.   7C ).
Analysis of the blood content of proinflammatory cytokines in LPS-treated
animals showed a substantial decrease in the content IL-6, IL-12p40 and IL-12p70 in fld animals compared with control ones (Fig. 8A) . A more exhaustive investigation of proinflamatory gene expression performed in the liver and the spleen of treated animals showed that many of those genes were less up-regulated in fld animals ( Fig.   8B , C). Significantly decreased levels of the proinflammatory protein iNOS, were also detected in peritoneal cells of LPS-exposed fld animals ( Fig. 8D) .
At the cellular level, we noticed that animals without treatment showed no differences in the percentage of total CD11b + cells in spleen. However, we found that (Fig. 9A) . On the other hand, spleens from LPS-treated animals showed an increase in CD11b + cell populations that was significantly higher in fld animals ( The recruitment of immune cells to the peritoneal cavity of non-treated and LPS-treated animals was also studied and no significant differences were found in the total number or type of cells recruited in fld versus wt animals ( Fig. 9B and C) . Overall these results suggest that fld animals experience a reduced proinflammatory response during endotoxin treatment that protects them from excessive damage.
Lipin-1 has a proinflammatory role in human macrophages
To address whether the proinflammatory effects of lipin-1 in murine macrophages also occur in human macrophages, experiments were conducted in blood monocytederived human macrophages that were made deficient in lipin-1 by nucleofection of a siRNA against lipin-1 (Fig. 10A) . We observed that, after LPS-treatment, the increases in mRNA levels for IL6, IL12a, IL12b and IL23a in control cells were less prominent in the lipin-1 deficient macrophages. These data are in accordance with our previous results in mice. encompasses, including the upregulation of many genes and proteins. In fact, TAG production is increased in activated macrophages (6, (27) (28) (29) , and its hydrolysis is an absolute requirement for efficient ATP supply and macrophage functioning (30) . Thus, the possibility exists that in the absence of lipin-1 macrophages may not be able to meet the necessary energy levels to fulfill all their activation requirements, resulting in the whole cell reprograming being altered. In such a scenario, a reduction of the whole activated transcriptional program would be expected. However, the wide analysis of gene expression performed in fld macrophages indicates that in these macrophages the gene transcription footprint is quite different than in wt cells, and is not the result of a mere reduction of transcriptional events. On the other hand, the activation of transcriptional effectors such as NF-κB does not seem to be altered in the absence of lipin-1, and this is a process that also needs ATP for the phosphorylation and degradation of the NF-κB inhibitor, IkB. Thus it could be deduced from these data that the effects observed for lipin-1 may not necessarily be related with reduced energy availability, at least during the early phases of activation. 
